EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Remimazolam used for sedation during spinal anesthesia puncture provides faster sedation effect and increase recovery rate compared to midazolam: a randomized controlled trial

Peipei Sun, Zhimin Tan, Lianxiong Liang, Jianbo Zhang, Xiaoqiang Li

Frontiers in Pharmacology · 20.10.2025 · 16

DOI: 10.3389/fphar.2025.1685312 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.10.2025. Verfasst von Peipei Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surgical time-out is essential for patient safety, requiring patients to remain conscious to verify their identity and surgical site. In China’s high-volume operating rooms, this step is crucial to prevent errors. Spinal anesthesia often induces anxiety, making sedation necessary. An ideal sedative must provide effective anxiolysis while allowing rapid recovery. This study compares remimazolam and midazolam to meet these dual demands and assess their cardiorespiratory safety.

Methods

This prospective, randomized controlled trial compared remimazolam and midazolam for sedation in patients undergoing elective ultrasound-guided spinal anesthesia. Patients were assigned to receive either remimazolam (0.1 mg/kg bolus, 0.5–1.0 mg/kg/h infusion) or midazolam (0.07 mg/kg bolus, 0.05–0.1 mg/kg/h infusion). Sedation was titrated to a target Richmond Agitation–Sedation Scale (RASS) score of −4. The primary outcome was the recovery time from RASS –4 to −1. Secondary outcomes included onset time, hemodynamic changes, respiratory parameters, and presences of adverse events.

Results

Of the 103 patients screened, 56 were eligible and randomized into the remimazolam (n = 28) and midazolam (n = 28) groups. The sedation onset time [1.5 (1.0, 2.0) min vs. 3.1 (2.8, 5.0) min, P < 0.001] and recovery time [3.9 (3.0, 5.2) min vs. 6.1 (3.1,10.0) min, P = 0.0016] was significantly shorter in the remimazolam group than midazolam group. Remimazolam had no significant impact on procedural time of ultrasound-guided spinal anesthesia. Both groups showed significant within-group decreases in mean arterial pressure during sedation (remimazolam: from 81.5 to 75 mmHg; midazolam: from 81.7 to 72.4 mmHg; P < 0.05), with no significant inter-group difference. At end of the procedure, remimazolam group had a higher respiratory rate than midazolam group (18.6 ± 3.3 vs. 16.8 ± 2.8) ( P < 0.05). No significant differences were observed in heart rate, end-tidal carbon dioxide partial pressure, and oxygen saturation between groups. Remimazolam was not associated with an increased risk of adverse events.

Conclusion

Remimazolam demonstrated superior recovery in sedation depth, with a significantly shorter time to regain consciousness (RASS –4 to −1), compared with midazolam in patients undergoing ultrasound-guided spinal anesthesia. No significant differences in circulatory or respiratory parameters were observed between groups, though the study may lack power to detect minor safety effects.

Schlagwörter

Stichwörter der Autor:innen

hemodynamic stabilitymidazolamrecovery timeremimazolamsedative agents

Autor:innen und Institutionen

  • Department of Anesthesiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Department of Anesthesiology, Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Central Hospital), Chengdu, Gansu, China.
  • Department of Anesthesiology, Heze Traditional Chinese Medicine Hospital, Heze, Shandong, China.

Zitieren

APA

Sun, P., Tan, Z., Liang, L., Zhang, J., & Li, X. (2025). Remimazolam used for sedation during spinal anesthesia puncture provides faster sedation effect and increase recovery rate compared to midazolam: a randomized controlled trial. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1685312

Vancouver

Sun P, Tan Z, Liang L, Zhang J, Li X. Remimazolam used for sedation during spinal anesthesia puncture provides faster sedation effect and increase recovery rate compared to midazolam: a randomized controlled trial. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1685312

BibTeX
@article{Sun2025,
  author = {Sun, Peipei and Tan, Zhimin and Liang, Lianxiong and Zhang, Jianbo and Li, Xiaoqiang},
  title = {Remimazolam used for sedation during spinal anesthesia puncture provides faster sedation effect and increase recovery rate compared to midazolam: a randomized controlled trial},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1685312}
}
Kostenlos starten →